Cellebrite DI (NASDAQ:CLBT) reported quarterly sales of $62.60 million which missed the analyst consensus estimate of $69.00 million by 9.28 percent.
Compass Point Downgrades Washington Trust Bancorp to Neutral, Lowers Price Target to $49
Compass Point analyst Laurie Havener downgrades Washington Trust Bancorp (NASDAQ:WASH) from Buy to Neutral and lowers the price target from $60 to $49.